Delivery Order SPE2DB22D2218-SPE2DB24FR2LE
Award Date 4/26/24
Potential Completion Date 4/29/24
Potential Value $3.3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,841.72 firm fixed-price delivery order contract is for the supply of ONFI 10 MG TABLET 100S, a pharmaceutical product. The award has an ultimate completion date of July 17, 2025 and is not set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $3,329.43 to provide 4564110750 ONFI 20 MG TABLET 100S. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,526.60 firm fixed-price delivery order is for the supply of 4566743308 ONFI 10 MG TABLET 100S. The contract has an ultimate completion date of December 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award is a $4,086.24 Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ONFI 10 MG TABLET 100S, with a period of performance ending on July 9, 2025. The contract is not set aside for any special category of business. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the delivery of ONFI 10 MG TABLET 100S to the Defense Logistics Agency (DLA) Troop Support Medical. The fixed-price delivery order contract, valued at $5,089.38, has an ultimate completion date of October 16, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,525.16 firm fixed-price delivery order contract is for the supply of ONFI 10 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of January 16, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award, valued at $4,023.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of 4,567,859,961 units of the pharmaceutical product ONFI 10 MG TABLET 100S. The contract has an ultimate completion date of April 10, 2025 and is a firm fixed-price contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,621.20 fixed-price delivery order is for the supply of ONFI 10 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of June 12, 2025 and is not associated with a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of a pharmaceutical product, 4564288087 ! ONFI 10 MG TABLET 100S. The contract is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $3,348.67. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,154.95 delivery order contract is for the provision of 4566597288 ONFI 10 MG TABLET 100S, a generic pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of December 4, 2024. Amerisourcebergen is the prime contractor, and there is no set-aside designation indicated. The...
- SPE2DB22D2218Indefinite Delivery Contract
- SPE2DB22D2218-SPE2DB24FR2LEDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $3,329.43 firm fixed price delivery order is for the supply of 100 count bottles of ONFI 20 MG tablets, with a completion date of April 29, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.
Generated 7/26/24, 9:09 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 4/26/24 |